Global Biopharmaceuticals Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Biopharmaceuticals Market
The research report studies the Biopharmaceuticals market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Biopharmaceuticals market size is projected to reach US$ 51410 million by 2027, from US$ 29900 million in 2020, at a CAGR of 8.0% during 2021-2027.
Global Biopharmaceuticals Scope and Segment
The global Biopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
by Application, this report covers the following segments
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Global Biopharmaceuticals market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Biopharmaceuticals key players in this market include:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira (Pfizer)
MYLAN
Sun pharma

TABLE OF CONTENT

1 Market Overview of Biopharmaceuticals
1.1 Biopharmaceuticals Market Overview
1.1.1 Biopharmaceuticals Product Scope
1.1.2 Biopharmaceuticals Market Status and Outlook
1.2 Global Biopharmaceuticals Market Size Overview by Region 2016 VS 2030VS 2027
1.3 Global Biopharmaceuticals Market Size by Region (2016-2027)
1.4 Global Biopharmaceuticals Historic Market Size by Region (2016-2030)
1.5 Global Biopharmaceuticals Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Biopharmaceuticals Market Size (2016-2027)
1.6.1 North America Biopharmaceuticals Market Size (2016-2027)
1.6.2 Europe Biopharmaceuticals Market Size (2016-2027)
1.6.3 Asia-Pacific Biopharmaceuticals Market Size (2016-2027)
1.6.4 Latin America Biopharmaceuticals Market Size (2016-2027)
1.6.5 Middle East & Africa Biopharmaceuticals Market Size (2016-2027)

2 Biopharmaceuticals Market Overview by Type
2.1 Global Biopharmaceuticals Market Size by Type: 2016 VS 2030 VS 2027
2.2 Global Biopharmaceuticals Historic Market Size by Type (2016-2030)
2.3 Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027)
2.4 Monoclonal Antibodies
2.5 Interferon
2.6 Colony-Stimulating Factor
2.7 Erythropoietin
2.8 Insulin
2.9 Vaccines
2.10 Growth Hormones
2.11 Others

3 Biopharmaceuticals Market Overview by Application
3.1 Global Biopharmaceuticals Market Size by Application: 2016 VS 2030 VS 2027
3.2 Global Biopharmaceuticals Historic Market Size by Application (2016-2030)
3.3 Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027)
3.4 Tumor
3.5 Diabetes
3.6 Cardiovascular
3.7 Hemophilia
3.8 Others

4 Biopharmaceuticals Competition Analysis by Players
4.1 Global Biopharmaceuticals Market Size by Players (2016-2030)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharmaceuticals as of 2020)
4.3 Date of Key Players Enter into Biopharmaceuticals Market
4.4 Global Top Players Biopharmaceuticals Headquarters and Area Served
4.5 Key Players Biopharmaceuticals Product Solution and Service
4.6 Competitive Status
4.6.1 Biopharmaceuticals Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Biopharmaceuticals Products, Services and Solutions
5.1.4 Roche Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.1.5 Roche Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Biopharmaceuticals Products, Services and Solutions
5.2.4 Amgen Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.2.5 Amgen Recent Developments
5.3 AbbVie
5.3.1 AbbVie Profile
5.3.2 AbbVie Main Business
5.3.3 AbbVie Biopharmaceuticals Products, Services and Solutions
5.3.4 AbbVie Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.3.5 Sanofi-Aventis Recent Developments
5.4 Sanofi-Aventis
5.4.1 Sanofi-Aventis Profile
5.4.2 Sanofi-Aventis Main Business
5.4.3 Sanofi-Aventis Biopharmaceuticals Products, Services and Solutions
5.4.4 Sanofi-Aventis Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.4.5 Sanofi-Aventis Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Profile
5.5.2 Johnson & Johnson Main Business
5.5.3 Johnson & Johnson Biopharmaceuticals Products, Services and Solutions
5.5.4 Johnson & Johnson Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.5.5 Johnson & Johnson Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Biopharmaceuticals Products, Services and Solutions
5.6.4 Pfizer Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.6.5 Pfizer Recent Developments
5.7 Novo Nordisk
5.7.1 Novo Nordisk Profile
5.7.2 Novo Nordisk Main Business
5.7.3 Novo Nordisk Biopharmaceuticals Products, Services and Solutions
5.7.4 Novo Nordisk Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.7.5 Novo Nordisk Recent Developments
5.8 Eli Lilly
5.8.1 Eli Lilly Profile
5.8.2 Eli Lilly Main Business
5.8.3 Eli Lilly Biopharmaceuticals Products, Services and Solutions
5.8.4 Eli Lilly Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.8.5 Eli Lilly Recent Developments
5.9 Novartis
5.9.1 Novartis Profile
5.9.2 Novartis Main Business
5.9.3 Novartis Biopharmaceuticals Products, Services and Solutions
5.9.4 Novartis Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.9.5 Novartis Recent Developments
5.10 Merck
5.10.1 Merck Profile
5.10.2 Merck Main Business
5.10.3 Merck Biopharmaceuticals Products, Services and Solutions
5.10.4 Merck Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.10.5 Merck Recent Developments
5.11 Sun
5.11.1 Sun Profile
5.11.2 Sun Main Business
5.11.3 Sun Biopharmaceuticals Products, Services and Solutions
5.11.4 Sun Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.11.5 Sun Recent Developments
5.12 3sbio
5.12.1 3sbio Profile
5.12.2 3sbio Main Business
5.12.3 3sbio Biopharmaceuticals Products, Services and Solutions
5.12.4 3sbio Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.12.5 3sbio Recent Developments
5.13 Changchun High Tech
5.13.1 Changchun High Tech Profile
5.13.2 Changchun High Tech Main Business
5.13.3 Changchun High Tech Biopharmaceuticals Products, Services and Solutions
5.13.4 Changchun High Tech Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.13.5 Changchun High Tech Recent Developments
5.14 CP Guojian
5.14.1 CP Guojian Profile
5.14.2 CP Guojian Main Business
5.14.3 CP Guojian Biopharmaceuticals Products, Services and Solutions
5.14.4 CP Guojian Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.14.5 CP Guojian Recent Developments
5.15 Biotech
5.15.1 Biotech Profile
5.15.2 Biotech Main Business
5.15.3 Biotech Biopharmaceuticals Products, Services and Solutions
5.15.4 Biotech Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.15.5 Biotech Recent Developments
5.16 Gelgen
5.16.1 Gelgen Profile
5.16.2 Gelgen Main Business
5.16.3 Gelgen Biopharmaceuticals Products, Services and Solutions
5.16.4 Gelgen Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.16.5 Gelgen Recent Developments
5.17 Innovent
5.17.1 Innovent Profile
5.17.2 Innovent Main Business
5.17.3 Innovent Biopharmaceuticals Products, Services and Solutions
5.17.4 Innovent Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.17.5 Innovent Recent Developments
5.18 Dong Bao
5.18.1 Dong Bao Profile
5.18.2 Dong Bao Main Business
5.18.3 Dong Bao Biopharmaceuticals Products, Services and Solutions
5.18.4 Dong Bao Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.18.5 Dong Bao Recent Developments
5.19 Ganlee
5.19.1 Ganlee Profile
5.19.2 Ganlee Main Business
5.19.3 Ganlee Biopharmaceuticals Products, Services and Solutions
5.19.4 Ganlee Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.19.5 Ganlee Recent Developments
5.20 United Laboratories
5.20.1 United Laboratories Profile
5.20.2 United Laboratories Main Business
5.20.3 United Laboratories Biopharmaceuticals Products, Services and Solutions
5.20.4 United Laboratories Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.20.5 United Laboratories Recent Developments
5.21 SANDOZ (NOVARTIS)
5.21.1 SANDOZ (NOVARTIS) Profile
5.21.2 SANDOZ (NOVARTIS) Main Business
5.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Products, Services and Solutions
5.21.4 SANDOZ (NOVARTIS) Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.21.5 SANDOZ (NOVARTIS) Recent Developments
5.22 Teva Pharmaceutical
5.22.1 Teva Pharmaceutical Profile
5.22.2 Teva Pharmaceutical Main Business
5.22.3 Teva Pharmaceutical Biopharmaceuticals Products, Services and Solutions
5.22.4 Teva Pharmaceutical Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.22.5 Teva Pharmaceutical Recent Developments
5.23 Hospira (Pfizer)
5.23.1 Hospira (Pfizer) Profile
5.23.2 Hospira (Pfizer) Main Business
5.23.3 Hospira (Pfizer) Biopharmaceuticals Products, Services and Solutions
5.23.4 Hospira (Pfizer) Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.23.5 Hospira (Pfizer) Recent Developments
5.24 MYLAN
5.24.1 MYLAN Profile
5.24.2 MYLAN Main Business
5.24.3 MYLAN Biopharmaceuticals Products, Services and Solutions
5.24.4 MYLAN Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.24.5 MYLAN Recent Developments
5.25 Sun pharma
5.25.1 Sun pharma Profile
5.25.2 Sun pharma Main Business
5.25.3 Sun pharma Biopharmaceuticals Products, Services and Solutions
5.25.4 Sun pharma Biopharmaceuticals Revenue (US$ Million) & (2016-2030)
5.25.5 Sun pharma Recent Developments

6 North America
6.1 North America Biopharmaceuticals Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Biopharmaceuticals Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Biopharmaceuticals Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Biopharmaceuticals Market Dynamics
11.1 Biopharmaceuticals Industry Trends
11.2 Biopharmaceuticals Market Drivers
11.3 Biopharmaceuticals Market Challenges
11.4 Biopharmaceuticals Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Choose License Type

Checkout Inquiry Sample